ARCHIVES

FDA Grants Priority Review To Two Drugs in NSCLC

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

May 30, 2008

Firm Wins Patent For Method, Apparatus For Cryoablation.

December 15, 2000

ASCO Honors Community Practices For Trial Participation.

June 1, 2007

More Breast Cancer Patients Opt To Remove Both Breasts

November 26, 2010

In Brief: Loberg Resigns From Bristol-Myers Squibb; Bloomfield Heads Cancer Center At Ohio State

February 14, 1997